News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Supriya Peshin: 6 of my posters have been accepted for ASCO GI Symposium
Supriya Peshin/X
Nov 11, 2024, 23:53

Supriya Peshin: 6 of my posters have been accepted for ASCO GI Symposium

Supriya Peshin, Internal Medicine Resident at Ballad Health, shared on LinkedIn:

“I am elated to announce that 6 of my posters have been accepted for presentation at the ASCO GI Symposium.

I eagerly anticipate reuniting with my exceptional mentors and engaging with leading pioneers in gastrointestinal oncology.

As my mentor so aptly put it, this will be an unparalleled experience, one I am sure to savor wholeheartedly.”

ASCO ASCO GI Symposium Ballad Health cancer OncoDaily Oncology Supriya Peshin
Special Coverage
Blog
Apr 11, 2025, 18:17
Michael Sapienza: Excited to Join the 2025 Screen Smart Dinner as a Panelist and Advisory Committee Member
Blog
Apr 11, 2025, 18:03
Tirzah Petta has been appointed as Director of the USC Norris Molecular Genomics Core
Blog
Apr 11, 2025, 17:57
David Planchard: Beating Durvalumab Monotherapy Post-CRT in Unresectable Stage III NSCLC
Blog
Apr 11, 2025, 17:51
Zoe Betancourt: Though ASCO Advocacy Summit is over, it’s not too late to take part in ASCO’s Week of Action
Blog
Apr 11, 2025, 17:43
Yan Leyfman: What happens after patients stop taking GLP-1 receptor agonists
Blog
Apr 11, 2025, 17:37
Lorenza Rimassa: Grateful to have worked on systemic therapy research for cholangiocarcinoma and biliary tract cancer
Blog
Apr 11, 2025, 17:27
Mark Hughes Foundation Centre for Brain Cancer Research Announces Six MHF Innovation Grant Recipients
Blog
Apr 11, 2025, 17:22
Antonio Passaro: Discussed the evolving treatment landscape for patients with EGFR-mutant NSCLC at ISCO25
Science
Apr 11, 2025, 16:22
Amar U Kishan: Validation and Derivation of MicroRNA-based Germline Signatures Predicting Radiation Toxicity in Prostate Cancer 
Blog
Apr 11, 2025, 15:47
Major microbiome disruption and Toxicities Following Idecabtagene Vicleucel in Multiple Myeloma patients
Opinion
Apr 11, 2025, 15:22
Amol Akhade Highlights Tarlatamab’s OS Benefit in SCLC
Blog
Apr 11, 2025, 15:01
Joseph Vento: ASCO update on PARPi and ARPI therapy in BRCA-mut mHRPC with Tian Zhang